Gedeon Richter Plc, based in Hungary, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NORGESTIMATE USP, with a corresponding US DMF Number 19429.
Remarkably, this DMF maintains an Active status since its submission on May 15, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 02, 2017, and payment made on April 18, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II